Dopamine receptor-modulated [35S]GTPγS binding in striatum of 6-hydroxydopamine-lesioned rats

被引:21
作者
Geurts, M
Hermans, E
Cumps, J
Maloteaux, JM
机构
[1] Univ Catholique Louvain, Pharmacol Lab, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, Dept Pharmaceut Sci, B-1200 Brussels, Belgium
关键词
S-35]GTP gamma S; striatum; 6-hydroxydopamine; receptor-G protein coupling; supersensitivity;
D O I
10.1016/S0006-8993(99)01812-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of dopamine receptor-G protein coupling in the development of striatal dopamine receptor supersensitivity was studied in rats with a 6-hydroxydopamine (6-OHDA)-induced unilateral lesion of the nigrostriatal pathway. This coupling was assessed by the measurement of dopamine agonist-induced guanosine 5'-O-(gamma[S-35]thio)triphosphate ([S-35]GTP gamma S) binding in striatal membranes, at different periods of time (1-5 weeks) following the microinjection of the neurotoxin. From the first to the fifth week following the lesion, basal and dopamine-stimulated [S-35]GTP gamma S-specific binding were found to be enhanced in the denervated striata as compared to their control counterpart. D-2 dopamine receptors were clearly demonstrated to be involved in this supersensitivity, as assessed by measuring N-propylnorapomorphine (NPA)-, quinpirole- and bromocriptine-induced [S-35]GTP gamma S-specific binding. The involvement of D-1 dopamine receptors was indirectly studied by the combination of dopamine with a saturating concentration of the selective and potent D-2 antagonist domperidone. In these conditions, the remaining response to dopamine was also found to be significantly increased following the lesion. These results are consistent with the hypothesis that, in addition to D-2 dopamine receptor upregulation, modulation of dopamine receptor-G protein interaction is involved in the hypersensitivity accompanying striatal dopamine depletion. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 36 条
[1]   REGULATION BY DOPAMINERGIC NEUROTRANSMISSION OF DOPAMINE-D2 MESSENGER-RNA AND RECEPTOR LEVELS IN THE STRIATUM AND NUCLEUS-ACCUMBENS OF THE RAT [J].
ANGULO, JA ;
COIRINI, H ;
LEDOUX, M ;
SCHUMACHER, M .
MOLECULAR BRAIN RESEARCH, 1991, 11 (02) :161-166
[2]   PARTIAL AND FULL DOPAMINE D1-RECEPTOR AGONISTS IN MICE AND RATS - RELATION BETWEEN BEHAVIORAL-EFFECTS AND STIMULATION OF ADENYLATE-CYCLASE ACTIVITY INVITRO [J].
ARNT, J ;
HYTTEL, J ;
SANCHEZ, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (02) :259-267
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BUTKERAIT P, 1994, J PHARMACOL EXP THER, V271, P422
[5]   REPEATED RESERPINE INCREASES STRIATAL DOPAMINE RECEPTOR AND GUANINE-NUCLEOTIDE BINDING-PROTEIN RNA [J].
BUTKERAIT, P ;
FRIEDMAN, E .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) :566-571
[6]   6-HYDROXYDOPAMINE LESIONS OF RAT SUBSTANTIA-NIGRA UP-REGULATE DOPAMINE-INDUCED PHOSPHORYLATION OF THE CAMP-RESPONSE ELEMENT-BINDING PROTEIN IN STRIATAL NEURONS [J].
COLE, DG ;
KOBIERSKI, LA ;
KONRADI, C ;
HYMAN, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9631-9635
[7]   ENHANCED ADENYLATE-CYCLASE ACTIVITY IN NEONATALLY DOPAMINE LESIONED RATS IS RELATED TO INCREASED GS-PROTEIN COUPLING [J].
COWBURN, R ;
YOUNG, D ;
LUTHMAN, J .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 207 (03) :271-274
[8]   DOPAMINE RECEPTOR-BINDING ENHANCEMENT ACCOMPANIES LESION-INDUCED BEHAVIORAL SUPERSENSITIVITY [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1977, 197 (4303) :596-598
[9]  
ENZ A, 1990, MOL PHARMACOL, V37, P560
[10]  
Geurts M, 1998, N-S ARCH PHARMACOL, V358, pR102